Bell Investment Advisors, Inc Adaptive Biotechnologies Corp Transaction History

Bell Investment Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$5.07 - $8.44 $400 - $666	-79 Reduced 17.87%	363 $1,000
Q2 2023 Aug 09, 2023	BUY	$6.19 - $8.78 $402 - $570	65 Added 17.24%	442 $2,000
Q1 2023 May 10, 2023	SELL	$7.8 - $10.11 $702 - $909	-90 Reduced 19.27%	377 $3,000
Q4 2022 Feb 08, 2023	SELL	$6.26 - $9.34 $932 - $1,391	-149 Reduced 24.19%	467 $3,000
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $3,035 - $5,916	467 Added 313.42%	616 $4,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $1,686 - $2,468	-67 Reduced 31.02%	149 $4,000
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $6,484 - $8,611	216 New	216 $7,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.